Results 21 to 30 of about 21,422 (185)
Pathogens, 2023 Bronchiolitis is a viral respiratory infection, with respiratory syncytial virus (RSV) being the most frequent agent, requiring hospitalization in 1% of affected children.
María Luz García-García +9 more
doaj +1 more source
Viral bronchiolitis management in hospitals in the UK [PDF]
Journal of Clinical Virology, 2018 Viral bronchiolitis is the leading cause of hospitalisation in infants less than a year old. The United Kingdom (UK) National Institute for Health and Care Excellence (NICE) published a guideline for the management of viral bronchiolitis in June 2015.This study aimed to prospectively survey the management of viral bronchiolitis in hospital Trusts in ...
Elliott J. Carande +4 more
openaire +4 more sources
Treatment of acute viral bronchiolitis
Residência Pediátrica, 2021 INTRODUCTION: Acute viral bronchiolitis (AVB) is one of the main respiratory infections in infants. Available information on the treatment of AVB in children under 2 years is reported, based on the most recent scientific evidence published in the literature.
Carla Dall’ Olio +2 more
openaire +1 more source
Measurement of the interbronchial angle in acute viral bronchiolitis [PDF]
Pediatric Pulmonology, 2021 Acute viral bronchiolitis (AVB) is the most common infection of the lower airways in children under 2 years of age. Attempts to determine the severity of the disease based on clinical and radiological manifestations are a major challenge. Measurements of the anatomy of the trachea, main bronchi and bronchioles are not limited to pure anthropometry, but
Gabriela F. Biondo +4 more
openaire +2 more sources
Allergology International, 2012 Background: Mannose-binding lectin (MBL) encoded by the MBL2 gene, is an important component of the innate immunity. Low levels have been linked with respiratory infections and both high and low levels with allergy and asthma.
Kirsi Nuolivirta +5 more
doaj +1 more source
Dendritic cells in viral bronchiolitis
Expert Review of Clinical Immunology, 2009 Dendritic cells (DCs) are major antigen-presenting cells that constitute a link between innate and adaptive immune responses, and are critical in the processes of control and elimination of viral infections. On the other hand, there is a large body of data strongly implicating respiratory viruses in morbidity during infancy through the induction of ...
Maggina, Paraskevi +4 more
openaire +4 more sources
Toll‐interacting protein polymorphisms in viral bronchiolitis outcomes [PDF]
Pediatrics International, 2021 AbstractBackgroundToll‐interacting protein is a key factor in regulating innate immunity responses via gatekeeping Toll‐like receptors. Genetic variance in innate immunity has been linked with susceptibility to infections. Children with viral bronchiolitis in infancy are at increased risk of later asthma.
Sari Törmänen +5 more
openaire +5 more sources
Treatment of Acute Viral Bronchiolitis [PDF]
The Open Microbiology Journal, 2011 Acute viral bronchiolitis represents the most common lower respiratory tract infection in infants and young children and is associated with substantial morbidity and mortality. Respiratory syncytial virus is the most frequently identified virus, but many other viruses may also cause acute bronchiolitis.
openaire +2 more sources
Bronchiolitis guidelines: what about the Italian situation in a primary care setting?
Italian Journal of Pediatrics, 2023 Acute viral bronchiolitis is the most common cause of hospitalization in children under 12 months of age. The variable clinical presentation and the potential for sudden deterioration of the clinical conditions require a close monitoring by healthcare ...
Federica Porcaro +3 more
doaj +1 more source
Something Is Changing in Viral Infant Bronchiolitis Approach
Frontiers in Pediatrics, 2022 Acute Viral Bronchiolitis is one of the leading causes of hospitalization in the first 12–24 months of life. International guidelines on the management of bronchiolitis broadly agree in recommending a minimal therapeutic approach, not recommending the use of bronchodilators.
Paolo Bottau +7 more
openaire +3 more sources